Participation in clinical trials
Strongly encourage and support patients with breast cancer to participate in clinical trials where a suitable trial is available
In view of the rapidly changing evidence in the field of breast cancer, clinicians should encourage women with early breast cancer to participate in clinical trials
Useful Links
How this guidance was developed
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process. Development of the practice point was informed by a source recommendation in the KCE 2013 guidelines (Belgium) that was designated as ‘Expert Opinion’ by the source guideline authors. In developing this practice point it was acknowledged that patients who participate in clinical trials have better outcomes than patients who do not, and that it is important for clinicians to understand the barriers and enablers of patient participation in clinical trials. This practice point reflects the key principle 'Research and clinical trials'.
Participation in clinical trials
Strongly encourage and support patients with breast cancer to participate in clinical trials where a suitable trial is available
Useful Links
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process. Development of the practice point was informed by a source recommendation in the KCE 2013 guidelines (Belgium) that was designated as ‘Expert Opinion’ by the source guideline authors. In developing this practice point it was acknowledged that patients who participate in clinical trials have better outcomes than patients who do not, and that it is important for clinicians to understand the barriers and enablers of patient participation in clinical trials. This practice point reflects the key principle 'Research and clinical trials'.